irinotecan has been researched along with asparagine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bencharit, S; Danks, MK; Howard-Williams, EL; Morton, CL; Potter, PM; Redinbo, MR | 1 |
Ando, M; Hanioka, N; Jinno, H; Kaniwa, N; Minami, H; Ohtsu, A; Ozawa, S; Saeki, M; Sai, K; Saijo, N; Saito, Y; Sawada, J; Shirao, K; Tanaka-Kagawa, T; Yoshida, T | 1 |
2 other study(ies) available for irinotecan and asparagine
Article | Year |
---|---|
Structural insights into CPT-11 activation by mammalian carboxylesterases.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Asparagine; Binding Sites; Camptothecin; Carboxylic Ester Hydrolases; Crystallography, X-Ray; Glycosylation; Irinotecan; Liver; Models, Molecular; Molecular Sequence Data; Pliability; Prodrugs; Rabbits; Structure-Activity Relationship | 2002 |
Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Asparagine; Aspartic Acid; Camptothecin; COS Cells; Exons; Genetic Variation; Glucuronates; Glucuronic Acid; Glucuronosyltransferase; Humans; Irinotecan; Japan; Mutation; Neoplasms; Polymorphism, Single Nucleotide; Transfection; UDP-Glucuronosyltransferase 1A9 | 2003 |